FDA to consider drug affordability when speeding up approvals: Makary
The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals…
FDA focuses attention on rejected drug decisions
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…